C. W. Lin

发表

Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: side chain exploration.

H. Sham, C. Collins, Gang Liu, 2006, Bioorganic & medicinal chemistry letters.

Cloning and characterization of the glucagon receptor from cynomologous monkey

T. Pederson, C. Collins, R. Reilly, 2004, Peptides.

Glucagon receptor antagonists for the treatment of type II diabetes: current prospects.

S. Djurić, C. W. Lin, N. Grihalde, 2002, Current opinion in investigational drugs.

trans-Activation and repression properties of the novel nonsteroid glucocorticoid receptor ligand 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four stereoisomers.

M. Nakane, J. Kuk, G. Carter, 2002, Molecular pharmacology.

Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists.

E. Bush, H. Sham, D. Beno, 2006, Journal of medicinal chemistry.

10 - Selective Cholecystokinin A and Cholecystokinin B/Gastrin Receptor Agonists

B. Bianchi, T. Miller, D. Witte, 1993 .

Excitatory effects of cholecystokinin octapeptide on rat nodose ganglion cells in vitro

N. Dun, S. Y. Wu, C. W. Lin, 1991, Brain Research.

Biaryl amide glucagon receptor antagonists.

Jyoti R. Patel, C. Collins, M. Winn, 2004, Bioorganic & medicinal chemistry letters.

Peripheral cholecystokinin type A receptors mediate oxytocin secretion in vivo

B. Bianchi, T. Miller, D. Witte, 1993, Regulatory Peptides.

Biaryl amide glucagon receptor antagonists.

Jyoti R. Patel, C. Collins, M. Winn, 2004, Bioorganic & medicinal chemistry letters.

Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells

Jean Martinez, A. Nadzan, D. Witte, 1992, Peptides.

Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors.

Vincent S Stoll, K. Longenecker, V. Stoll, 2006, Biochemistry.

Induced expression of neuronal membrane attack complex and cell death by Alzheimer's β-amyloid peptide

S. Meri, Chi-Ming Lee, K. Shiosaki, 1998, Brain Research.

Amino acid-derived piperidides as novel CCKB ligands with anxiolytic-like properties

J. Brioni, M. Holladay, M. Stashko, 1995 .

Development of non-sulfated tetrapeptides as potent and selective CCK-A receptor agonists

B. Bianchi, A. Nadzan, K. Shiosaki, 1991 .

(5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1- ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431).

M. Michaelides, M. Williams, S. Didomenico, 1995, Journal of medicinal chemistry.

Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-a receptor agonists.

B. Bianchi, A. Nadzan, K. Shiosaki, 1991, Journal of medicinal chemistry.

Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization.

R. Mackenzie, D. Frail, D. Witte, 1993, Molecular pharmacology.